Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19 is a research paper published in Open Forum Infectious Diseases (2020). On theSindex it has a DataRank of 2.2. It has been cited 52 times, with 49 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.596
From this paper's citation signal
Citation Network Contribution
1.6
From 40 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 49 citers.
National Institute of Mental Health
Grant: K23MH121220
Fogarty International Center
Grant: D43TW009345
National Institute of Allergy and Infectious Diseases
Grant: K08AI134262
National Institute of Allergy and Infectious Diseases
Grant: K23AI138851
National Institute of Allergy and Infectious Diseases
Grant: T32AI055433
National Institutes of Health
Grant: T32GM007347
National Institutes of Health
Grant: F30CA236157
NINDS NIH HHS
Grant: R01 NS086312
NIAID NIH HHS
Grant: T35 AI118620
FIC NIH HHS
Grant: L30 TW011500
NINDS NIH HHS
Grant: R01 NS110519
NIGMS NIH HHS
Grant: T32 GM152284
NCATS NIH HHS
Grant: UL1 TR002494
National Institutes of Health
Grant: 3D43TW009345-14S1
Northern Pacific Global Health Leadership, Education, and Development for Early-career Researchers (NPGH LEADERs)
National Institutes of Health
Grant: 1K23MH121220-01
Neuroinflammation and Modulating Factors in Depression and HIV
National Institutes of Health
Grant: 5F30CA236157-02
Modulation of the anti-tumor immune response by Major Histocompatibility Class-II expression on tumor cells
National Institutes of Health
Grant: 5K08AI134262-04
Evaluating Antiretroviral Pharmacology in the Female Genital Tract to Optimize HIV Prevention
National Institutes of Health
Grant: 5K23AI138851-05
Evaluation of CRAG screening with enhanced antifungal therapy for asymptomatic CRAG-positive persons
National Institutes of Health
Grant: 5T32GM007347-08
MEDICAL SCIENTIST TRAINING PROGRAM
University of Minnesota
Fields of Study
Keywords
Sustainable Development Goals